Year in Review: Lymphoma

]]>(MedPage Today) -- The top lymphoma news in 2019 included broadened Medicare coverage of chimeric antigen receptor (CAR) T-cell therapy, further developments with this novel treatment, a half-dozen notable approvals from the FDA, and escalated...